Abstract: The present invention encompasses vaccines or compositions comprising the chimeric KSAC protein that possesses immunogenic and protective properties, and methods of use including administering to an animal the antigenic KSAC protein thereof to protect animals. The invention also encompasses methods for making and producing the soluble, disaggregated, refolded or active proteins from inclusion bodies produced from prokaryotes or eukaryotes.
Type:
Grant
Filed:
February 5, 2016
Date of Patent:
July 30, 2019
Assignee:
BOEHRINGER INGELHEIM ANIMAL HEATLH USA INC.
Inventors:
Laurent Bernard Fischer, Nicolas Pierre Yves Carboulec, Fabien Lux